Developer docs
API playgroundTry for free, no card

Search company profiles

Monogram Orthopedics

Full company profile

uuid0000zwc

Namestring
Monogram Orthopedics
Legal namestring
Monogram Technologies Inc.
Company typeenum
Public
Founded yearint
2016
Descriptiontext

Monogram Orthopedics (legal entity Monogram Technologies Inc.) is a medical device company that develops precision surgical robotics combined with 3D-printed personalized implants for orthopedic joint replacement, primarily total knee arthroplasty. Its core platform centers on the FDA 510(k)-cleared mBôs TKA System — an active robotic system designed to perform precise bone cuts that accommodate customized 3D-printed implants matched to each patient's anatomy. The platform is augmented by the in-development mVision registration and tracking technology and a clinical planning software suite that uses machine learning algorithms to process patient image data and automate implant position and alignment optimization.

The company serves orthopedic surgeons, hospitals, and ambulatory surgical centers performing knee and hip replacement procedures, and ultimately the patients receiving personalized implants. Its commercial model combines hardware sales (the robotic system, instruments, and personalized 3D-printed implants), software licensing (surgical planning and ML algorithms), and professional services (training, implementation, and support), with pricing negotiated on a quote basis with healthcare institutions. Pre-acquisition go-to-market was an enterprise field-sales motion targeting surgeons and hospital systems, supplemented by digital marketing, YouTube surgeon-panel content, and earned media coverage.

The company was founded in 2016 in Austin, Texas, grew to 11-50 employees, raised over $70 million cumulatively through Regulation A+ and Regulation CF retail investor campaigns (including a $13 million round in July 2024), and achieved a Nasdaq listing. On October 7, 2025, Monogram Technologies was acquired by Zimmer Biomet, and its products are now distributed through Zimmer Biomet's global orthopedic sales network. The company previously held an academic research partnership with UCLA, whose studies demonstrated the Monogram process was approximately seven times more stable than current hip replacement techniques.

Short descriptiontext

Monogram Orthopedics develops precision surgical robotics combined with 3D-printed personalized implants for orthopedic joint replacement, primarily serving orthopedic surgeons and hospitals performing total knee arthroplasty. The company was acquired by Zimmer Biomet in October 2025.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopedic surgical robotics, 3D-printed joint implants, robotic knee replacement, personalized orthopedic implants, surgical navigation systems
Industry6 codes
1Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryYes
2Surgical Robotics & Computer-Assisted Surgery Platforms
CodeHLAHADAFPrimaryNo
3Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
CodeHLAHAEAAPrimaryNo
43D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
CodeHLAHAEAJPrimaryNo
5Medical & Dental 3D Printing Services (patient-specific devices, dental labs)
CodeIMAAADAGPrimaryNo
6Healthcare & Assistive Robotics
CodeHDAAAIACPrimaryNo
NAICS code3 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopedic Surgical Robotics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Device Hardware Sales
TypeHardware Sales
Description

Sale of the mBôs surgical robotic system and associated surgical instruments to healthcare providers and hospitals.

monogramtechnologies.com
2Personalized 3D-Printed Implants
TypeHardware Sales
Description

Sale of customized patient-specific implants manufactured to individual anatomical specifications.

monogramtechnologies.com
3Software Licensing
TypeLicensing Royalties
Description

Licensing of surgical planning software and machine learning algorithms for clinical use.

monogramtechnologies.com
4Professional Services
TypeProfessional Services
Description

Training, implementation, and support services for the robotic surgical system and clinical staff.

monogramtechnologies.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Monogram Orthopedics develops and manufactures precision robotic surgical systems (the FDA 510(k)-cleared mBôs™ TKA System) combined with proprietary 3D-printed personalized joint implants for total knee arthroplasty and hip replacement procedures. The integrated platform combines active robotics for precise bone cutting, machine-learning-powered surgical planning software, and patient-specific implants custom-manufactured to match individual anatomy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Studies with UCLA showed the Monogram process was approximately seven times more stable than current hip replacement techniques
Product overview1 text field

Monogram Orthopedics offers a unified surgical robotics platform centered on the FDA 510(k)-cleared mBôs™ TKA System, which integrates precision robotics with customized 3D-printed implants for total knee arthroplasty. The platform includes mVision for registration and tracking, and clinical planning software powered by machine learning algorithms. Together, these components enable personalized joint replacement procedures designed to achieve perfect surgical cuts and optimal implant fit for each patient.

Product and service2 records
1mBôs™ TKA System
CategorySurgical Robotic System
Description

An active robotic surgical system for total knee arthroplasty (TKA) that performs precise bone cuts for fitting customized 3D-printed implants. FDA 510(k) cleared and intended for orthopedic surgeons and hospitals performing knee replacement procedures.

2Personalized 3D-Printed Joint Implants
CategoryOrthopedic Implants
Description

Customized 3D-printed joint implants matched to each patient's unique anatomy, designed to decrease micro-mobility and increase implant acceptance. Used in conjunction with the mBôs robotic system for knee and hip replacement.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-07
Description

Zimmer Biomet acquired Monogram Technologies in October 2025. The acquisition integrates Monogram's precision robotics and 3D-printed personalized implant technology into Zimmer Biomet's orthopedic portfolio. Zimmer Biomet is a major medical device company with established hospital and surgeon distribution networks globally.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic research partnership for orthopedic studies. UCLA conducted studies demonstrating that the Monogram process was approximately seven times more stable than current hip replacement techniques.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Onkos Surgical designs personalized 3D-printed implants for complex orthopedic oncology and revision procedures, making it a partial competitor in the patient-specific implant niche adjacent to Monogram.

TypeDirect peer
Description

Smith+Nephew's CORI handheld robotics system targets the same knee arthroplasty market as Monogram's mBôs and is a direct competitor for ambulatory surgery centers and hospital robotics placements.

TypeEmerging player
Description

Conformis specializes in patient-specific knee and hip implants manufactured to individual anatomy, overlapping with Monogram's personalized 3D-printed implant offering, though without an integrated robotics platform.

TypeBroad incumbent
Description

Exactech is an established orthopedic implant manufacturer offering personalized knee and hip arthroplasty products, representing a broader incumbent whose portfolio overlaps with Monogram's personalized implant thesis.

TypeEmerging player
Description

Renishaw is a precision engineering company with surgical robotics products; while primarily in neurosurgery, its additive manufacturing and robotic positioning capabilities are technologically comparable to Monogram's stack.

TypeDirect peer
Description

Zimmer Biomet's ROSA robotics platform is the parent of Monogram and competes in the same orthopedic robotics category; relevant both as a competing system and as the acquirer that now controls Monogram's commercial path.

TypeOthers
Description

Materialise provides 3D printing software and personalized medical device manufacturing services, including patient-specific implants and surgical planning tools, making it an enabling technology provider rather than a direct competitor.

TypeDirect peer
Description

DePuy Synthes' VELYS robotic-assisted solution is a direct competitor in orthopedic joint replacement robotics, with similar positioning around digital surgical planning and table-mounted robotic execution.

TypeDirect peer
Description

THINK Surgical develops active robotic systems for orthopedic surgery, including TMINI and TSolution One, and is the closest pure-play independent competitor in the active robotic bone-cutting category.

TypeDirect peer
Description

Stryker's Mako robotic-arm assisted surgery platform is the dominant orthopedic robotics system for knee and hip arthroplasty, directly competing with Monogram's mBôs system for surgeon adoption and hospital capital budgets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Monogram Orthopedics

Orthopedic Surgical Roboticsmonogramorthopedics.com

Monogram Orthopedics develops precision surgical robotics combined with 3D-printed personalized implants for orthopedic joint replacement, primarily serving orthopedic surgeons and hospitals performing total knee arthroplasty. The company was acquired by Zimmer Biomet in October 2025.

What Monogram Orthopedics does

Monogram Orthopedics (legal entity Monogram Technologies Inc.) is a medical device company that develops precision surgical robotics combined with 3D-printed personalized implants for orthopedic joint replacement, primarily total knee arthroplasty. Its core platform centers on the FDA 510(k)-cleared mBôs TKA System — an active robotic system designed to perform precise bone cuts that accommodate customized 3D-printed implants matched to each patient's anatomy. The platform is augmented by the in-development mVision registration and tracking technology and a clinical planning software suite that uses machine learning algorithms to process patient image data and automate implant position and alignment optimization.

The company serves orthopedic surgeons, hospitals, and ambulatory surgical centers performing knee and hip replacement procedures, and ultimately the patients receiving personalized implants. Its commercial model combines hardware sales (the robotic system, instruments, and personalized 3D-printed implants), software licensing (surgical planning and ML algorithms), and professional services (training, implementation, and support), with pricing negotiated on a quote basis with healthcare institutions. Pre-acquisition go-to-market was an enterprise field-sales motion targeting surgeons and hospital systems, supplemented by digital marketing, YouTube surgeon-panel content, and earned media coverage.

The company was founded in 2016 in Austin, Texas, grew to 11-50 employees, raised over $70 million cumulatively through Regulation A+ and Regulation CF retail investor campaigns (including a $13 million round in July 2024), and achieved a Nasdaq listing. On October 7, 2025, Monogram Technologies was acquired by Zimmer Biomet, and its products are now distributed through Zimmer Biomet's global orthopedic sales network. The company previously held an academic research partnership with UCLA, whose studies demonstrated the Monogram process was approximately seven times more stable than current hip replacement techniques.

Monogram Orthopedics firmographics

Firmographics
Name
Monogram Orthopedics
Legal name
Monogram Technologies Inc.
Website
https://monogramorthopedics.com
Company type
Public
Founded year
2016
Operating status
Acquired
Headcount range
11–50 employees
Short description
Monogram Orthopedics develops precision surgical robotics combined with 3D-printed personalized implants for orthopedic joint replacement, primarily serving orthopedic surgeons and hospitals performing total knee arthroplasty. The company was acquired by Zimmer Biomet in October 2025.
Ownership category
akta.pro rank

Monogram Orthopedics industry classification

Industry
Product category
Orthopedic Surgical Robotics
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)
akta.pro secondary industries
Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF), Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG), Healthcare & Assistive Robotics (HDAAAIAC)

Keywords

  • Orthopedic surgical robotics
  • 3D-printed joint implants
  • Robotic knee replacement
  • Personalized orthopedic implants
  • Surgical navigation systems

Where Monogram Orthopedics is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Monogram Orthopedics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Hardware Sales: Sale of the mBôs surgical robotic system and associated surgical instruments to healthcare providers and hospitals.
  2. Personalized 3D-Printed Implants: Sale of customized patient-specific implants manufactured to individual anatomical specifications.
  3. Software Licensing: Licensing of surgical planning software and machine learning algorithms for clinical use.
  4. Professional Services: Training, implementation, and support services for the robotic surgical system and clinical staff.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Monogram Orthopedics product offering

Product offering

Core offering

Monogram Orthopedics develops and manufactures precision robotic surgical systems (the FDA 510(k)-cleared mBôs™ TKA System) combined with proprietary 3D-printed personalized joint implants for total knee arthroplasty and hip replacement procedures. The integrated platform combines active robotics for precise bone cutting, machine-learning-powered surgical planning software, and patient-specific implants custom-manufactured to match individual anatomy.

Product overview

Monogram Orthopedics offers a unified surgical robotics platform centered on the FDA 510(k)-cleared mBôs™ TKA System, which integrates precision robotics with customized 3D-printed implants for total knee arthroplasty. The platform includes mVision for registration and tracking, and clinical planning software powered by machine learning algorithms. Together, these components enable personalized joint replacement procedures designed to achieve perfect surgical cuts and optimal implant fit for each patient.

Differentiator

Problem solved

Functional benefit

Products and services

  • mBôs™ TKA System An active robotic surgical system for total knee arthroplasty (TKA) that performs precise bone cuts for fitting customized 3D-printed implants. FDA 510(k) cleared and intended for orthopedic surgeons and hospitals performing knee replacement procedures.
  • Personalized 3D-Printed Joint Implants Customized 3D-printed joint implants matched to each patient's unique anatomy, designed to decrease micro-mobility and increase implant acceptance. Used in conjunction with the mBôs robotic system for knee and hip replacement.

Quantifiable outcome

  • Studies with UCLA showed the Monogram process was approximately seven times more stable than current hip replacement techniques

Companies that use Monogram Orthopedics

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Monogram Orthopedics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Monogram Orthopedics partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • Zimmer BiometcoreStrategic or Co-development Partner · 7 October 2025Zimmer Biomet acquired Monogram Technologies in October 2025. The acquisition integrates Monogram's precision robotics and 3D-printed personalized implant technology into Zimmer Biomet's orthopedic portfolio. Zimmer Biomet is a major medical device company with established hospital and surgeon distribution networks globally.
  • UCLAminorStrategic or Co-development PartnerAcademic research partnership for orthopedic studies. UCLA conducted studies demonstrating that the Monogram process was approximately seven times more stable than current hip replacement techniques.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Monogram Orthopedics competitors and assessment

Company assessment

Emerging players

  • Onkos Surgical: Onkos Surgical designs personalized 3D-printed implants for complex orthopedic oncology and revision procedures, making it a partial competitor in the patient-specific implant niche adjacent to Monogram.
  • Conformis: Conformis specializes in patient-specific knee and hip implants manufactured to individual anatomy, overlapping with Monogram's personalized 3D-printed implant offering, though without an integrated robotics platform.
  • Renishaw (Neuromate / neurosurgical robotics): Renishaw is a precision engineering company with surgical robotics products; while primarily in neurosurgery, its additive manufacturing and robotic positioning capabilities are technologically comparable to Monogram's stack.

Direct peers

  • Smith+Nephew (CORI): Smith+Nephew's CORI handheld robotics system targets the same knee arthroplasty market as Monogram's mBôs and is a direct competitor for ambulatory surgery centers and hospital robotics placements.
  • Zimmer Biomet (ROSA): Zimmer Biomet's ROSA robotics platform is the parent of Monogram and competes in the same orthopedic robotics category; relevant both as a competing system and as the acquirer that now controls Monogram's commercial path.
  • Johnson & Johnson DePuy Synthes (VELYS): DePuy Synthes' VELYS robotic-assisted solution is a direct competitor in orthopedic joint replacement robotics, with similar positioning around digital surgical planning and table-mounted robotic execution.
  • THINK Surgical: THINK Surgical develops active robotic systems for orthopedic surgery, including TMINI and TSolution One, and is the closest pure-play independent competitor in the active robotic bone-cutting category.
  • Stryker (Mako): Stryker's Mako robotic-arm assisted surgery platform is the dominant orthopedic robotics system for knee and hip arthroplasty, directly competing with Monogram's mBôs system for surgeon adoption and hospital capital budgets.

Broad incumbents

  • Exactech: Exactech is an established orthopedic implant manufacturer offering personalized knee and hip arthroplasty products, representing a broader incumbent whose portfolio overlaps with Monogram's personalized implant thesis.

Others

  • Materialise: Materialise provides 3D printing software and personalized medical device manufacturing services, including patient-specific implants and surgical planning tools, making it an enabling technology provider rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Monogram Orthopedics social profiles

Digital presence

Monogram Orthopedics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Monogram Orthopedics leadership team

Management profile

Number of profiles

Profiles3 records

Monogram Orthopedics funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Monogram Orthopedics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Monogram Orthopedics

What does Monogram Orthopedics do?

Monogram Orthopedics develops and manufactures precision robotic surgical systems (the FDA 510(k)-cleared mBôs™ TKA System) combined with proprietary 3D-printed personalized joint implants for total knee arthroplasty and hip replacement procedures. The integrated platform combines active robotics for precise bone cutting, machine-learning-powered surgical planning software, and patient-specific implants custom-manufactured to match individual anatomy.

Is Monogram Orthopedics a public or private company?

Monogram Orthopedics is a public company. It is classified as corporate owned and is currently acquired.

When was Monogram Orthopedics founded?

Monogram Orthopedics was founded in 2016. It employs 11 to 50 people.

Where is Monogram Orthopedics based?

Monogram Orthopedics is headquartered in Austin, United States, in the North America region.

How does Monogram Orthopedics make money?

Four revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are personalized 3D-Printed Implants, software Licensing and professional Services.

Who are Monogram Orthopedics's main competitors?

Emerging players on record are Onkos Surgical, Conformis and Renishaw (Neuromate / neurosurgical robotics). Direct peers are Smith+Nephew (CORI), Zimmer Biomet (ROSA), Johnson & Johnson DePuy Synthes (VELYS), THINK Surgical and Stryker (Mako). Exactech is listed as a broad incumbent. Materialise is listed as an others.

Does Monogram Orthopedics have an API?

No public API is recorded for Monogram Orthopedics.

What industry is Monogram Orthopedics in?

Monogram Orthopedics's product category is Orthopedic Surgical Robotics. Its primary akta.pro industry code is HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine), with a secondary code of HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms. Its NAICS code is 3345 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YouTubeJuly Medtech Recap: Q2 Earnings, Deals, and Robotic EndoscopyThis article is a summary of a podcast episode titled 'July Medtech Recap' that analyzes Q2 earnings, M&A activity, and market trends in the medical technology sector. It highlights specific industry developments including Zimmer Biomet's acquisition of Monogram and strategic moves by companies like Olympus and Think Surgical in robotics and diagnostics. The content serves as an agenda for a discussion on medtech resilience and growth strategies rather than reporting a single discrete news event.YouTubeOn-Demand Webinar for Practical Steps for Assessing Supplier Risk led by Kevin PoseyIntellect has released an on-demand webinar led by Kevin Posey from Monogram Orthopedics, focusing on practical strategies for assessing and minimizing supplier risk. The session covers proven tools and criteria to help professionals manage risks driven by quality issues, supply chain disruptions, and regulatory pressure.YahooMonogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in IndiaMonogram Technologies received CDSCO approval to import its mBôs TKA system for a 102-patient multi-center clinical trial in India with Shalby Hospitals. The trial will evaluate safety and effectiveness with a three-month follow-up, with patient enrollment expected to start shortly and first surgeries within 90 business days.DealmakerRobotics Venture Funding: Navigating Capital Raising in 2025DealMaker published an article on robotics venture funding strategies in 2025, highlighting how direct-to-investor fundraising through Regulation A+ and Regulation CF pathways offers an alternative to traditional VC for hardware-intensive robotics companies facing long R&D cycles and capital-intensive development. The article showcases success stories including Monogram Orthopaedics, which raised over $70 million across multiple retail investor campaigns and achieved a Nasdaq listing; Knightscope, which raised $70 million from 28,000 investors before its 2022 IPO; and Miso Robotics, which secured $50 million from over 15,000 investors. The piece positions DealMaker's platform as a solution for robotics founders struggling with traditional fundraising constraints while emphasizing community-building benefits of retail investor engagement.DealmakerCapital Raise Technology: Leveraging It to Streamline Your FundraisingDealMaker provides technology and strategic support for companies to raise capital through online platforms, highlighting success stories such as Miso Robotics and Monogram Orthopaedics. Monogram Orthopaedics utilized DealMaker's platform to raise over $80 million from retail investors across multiple campaigns, eventually leading to its Nasdaq listing in 2023. The article emphasizes how leveraging fundraising technology can streamline administrative tasks, enhance investor experience, and secure growth funding.GlobeNewswireMonogram Orthopaedics Selects RTI Connext Anywhere as the Connectivity Software Solution for Remote SurgeryMonogram Orthopaedics selected RTI Connext Anywhere for real-time connectivity in its fully remote simulated robotic surgery. The company completed the world's first remote robotically-assisted Total Knee Arthroplasty on a cadaver leg, with surgeons in New York controlling a robot in Texas. RTI's DDS-based solution enables low-latency, secure communication for telesurgery.BenzingaHow 13,509 Retail Investors All Made 1,018% Gains In Under 15 MonthsMonogram Orthopedics Inc. saw its stock price surge to $42.05 following its IPO on May 18, generating approximately 1,018% gains for the 13,509 retail investors who participated in its prior equity crowdfunding rounds via StartEngine. The article highlights this outcome as a significant return compared to traditional public market investments, noting that early-stage investors benefited from substantial valuation increases while post-IPO buyers face higher risks. It contrasts Monogram's success with the underperformance of other recent IPOs like Rivian and Uber at their public debut valuations.BenzingaRevolutionizing Knee Replacements: Monogram Orthopedics Gears Up For Nasdaq IPO With Over 14,000 Retail IMonogram Orthopedics is preparing for a NASDAQ listing under ticker MGRM on May 18th, marking the second prominent IPO in the equity crowdfunding space following Knightscope's 2022 listing. The company raised $23.7 million from over 14,000 retail investors on StartEngine, making it the platform's third-largest fundraise, and has conducted additional raises through SeedInvest and DealMaker. The medtech startup develops personalized 3D-printed orthopedic implants and robotic surgical systems for knee replacements, targeting a $19.4 billion market where 20% of patients suffer post-surgery chronic pain and 40% of revisions result from mechanical loosening.GlobeNewswireMonogram Orthopaedics Engages Equity Stock Transfer as Exclusive Transfer AgentMonogram Orthopaedics engaged Equity Stock Transfer as exclusive SEC-registered transfer agent for its Series B and Series C Preferred Stock. The company has raised approximately $38 million through July 2022. The transfer agent will assist tens of thousands of investors with securities safekeeping and transfer.